Acta Pharmaceutica Sinica B : Impact Factor & More
eISSN: 2211-3843pISSN: 2211-3835
Open AccessShare this on:
Key Metrics
CiteScore 
15.9
Eigenfactor
< 0.001
Impact Factor
10 - 15
Scite Index
0.95 5-Year SI
SJR
Q1Pharmacology, Toxicology and Pharmaceutics (all)
SNIP
2.59
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B Journal Specifications
| Overview | |
| Publisher | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
| Language | English |
| Frequency | Bi-monthly |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Insititute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association |
| Frequency | Bi-monthly |
| Publication Start Year | 2011 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Acta Pharmaceutica Sinica B ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Acta Pharmaceutica Sinica B
A new approach to discovering a broad-spectrum anti-respiratory virus drug: Tubeimoside II modulates host factor PACT to potentiate the RIG-I antiviral pathway
- 1 May 2026
- Acta Pharmaceutica Sinica B
Outer membrane vesicles: Versatile nanocarriers for therapeutic delivery and immune modulation.
- 1 Apr 2026
- Acta pharmaceutica Sinica. B
FlowDock: A unified flow-based framework for flexible protein-ligand docking and binding affinity prediction
- 1 Apr 2026
- Acta Pharmaceutica Sinica B
Editor Profiles: Guest Editors of Special Column on Hot Topic Reviews in Drug (II).
- 1 Apr 2026
- Acta pharmaceutica Sinica. B
Microneedle-based delivery for autoimmune diseases: Emerging opportunities and unresolved questions.
- 1 Apr 2026
- Acta pharmaceutica Sinica. B
Attenuating AAV-triggered innate immunity in the adult mouse nervous system via cGAS–STING pathway inhibition
- 1 Apr 2026
- Acta Pharmaceutica Sinica B
A new approach to discovering a broad-spectrum anti-respiratory virus drug: Tubeimoside II modulates host factor PACT to potentiate the RIG-I antiviral pathway
- 1 May 2026
- Acta Pharmaceutica Sinica B
Outer membrane vesicles: Versatile nanocarriers for therapeutic delivery and immune modulation.
- 1 Apr 2026
- Acta pharmaceutica Sinica. B
FlowDock: A unified flow-based framework for flexible protein-ligand docking and binding affinity prediction
- 1 Apr 2026
- Acta Pharmaceutica Sinica B
Editor Profiles: Guest Editors of Special Column on Hot Topic Reviews in Drug (II).
- 1 Apr 2026
- Acta pharmaceutica Sinica. B
Microneedle-based delivery for autoimmune diseases: Emerging opportunities and unresolved questions.
- 1 Apr 2026
- Acta pharmaceutica Sinica. B
Attenuating AAV-triggered innate immunity in the adult mouse nervous system via cGAS–STING pathway inhibition
- 1 Apr 2026
- Acta Pharmaceutica Sinica B
FAQs on Acta Pharmaceutica Sinica B
How long has Acta Pharmaceutica Sinica B been actively publishing? 
What is the publishing frequency of Acta Pharmaceutica Sinica B?
How many articles did Acta Pharmaceutica Sinica B publish last year?
What is the eISSN & pISSN for Acta Pharmaceutica Sinica B?
What is Citescore for Acta Pharmaceutica Sinica B?
What is SNIP score for Acta Pharmaceutica Sinica B?
What is the SJR for Acta Pharmaceutica Sinica B?
Who is the publisher of Acta Pharmaceutica Sinica B?
